Cargando…
Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery
BACKGROUND: Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines provide a class I recommendation for patients with type 2 diabetes mellitus and multivessel coronary artery disease (CAD) to be treated with coronary artery bypass graft surgery (CABG). However, these...
Autores principales: | Perry, Andrew, Chung, Matthew J., Novak, Eric, Krone, Ronald, Brown, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460751/ https://www.ncbi.nlm.nih.gov/pubmed/31093573 http://dx.doi.org/10.1186/s41512-019-0048-7 |
Ejemplares similares
-
To Defer or Not Defer? The Challenges of Physiology in Acute Coronary
Syndromes
por: Campos, Carlos M., et al.
Publicado: (2018) -
Nonsternotomy multivessel coronary artery bypass grafting: A key development in cardiac surgery
por: Ruel, Marc
Publicado: (2021) -
Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis
por: Zhu, Peng, et al.
Publicado: (2015) -
Unexpected Evolution After Multivessel Coronary Artery Bypass Grafting in a Patient With Kawasaki Disease
por: Victor, Samjeris, et al.
Publicado: (2021) -
The Feasibility and Early Results of Multivessel Minimally Invasive Coronary Artery Bypass Grafting for All Comers
por: Demirsoy, Ergun, et al.
Publicado: (2023)